Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLAR

Creative Commons License

ATAMAN Ş., Surmeli Z. S., Sunar İ., Ozdemirel E., AKINCI A., Bodur H., ...Daha Fazla

ARCHIVES OF RHEUMATOLOGY, cilt.30, sa.4, ss.271-284, 2015 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 4
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5606/archrheumatol.2015.5654
  • Dergi Adı: ARCHIVES OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.271-284
  • Anahtar Kelimeler: Biologic disease modifying anti-rheumatic drugs, rheumatoid arthritis, synthetic disease modifying anti-rheumatic drugs, treatment recommendations, ADALIMUMAB PLUS METHOTREXATE, INHIBITOR TOFACITINIB CP-690,550, NECROSIS-FACTOR INHIBITORS, DOUBLE-BLIND, INADEQUATE RESPONSE, STRATEGY TRIAL, JAK INHIBITOR, TOCILIZUMAB MONOTHERAPY, ANKYLOSING-SPONDYLITIS, COMBINATION ETANERCEPT
  • Ankara Üniversitesi Adresli: Evet

Özet

Objectives: This study aims to report Turkish League Against Rheumatism's assessment on the compliance of European League Against Rheumatism 2013 treatment recommendations for rheumatoid arthritis with practices in Turkish rheumatology clinics and adaptations for Turkey.